Endometrial (Uterine) Cancer

+ -Text Size

Early Detection, Diagnosis, and Staging TOPICS

Survival by stage of endometrial cancer

Survival rates are often used by doctors as a standard way of discussing a person's prognosis (outlook). Some patients with cancer may want to know the survival statistics for people in similar situations, while others may not find the numbers helpful, or may even not want to know them. If you decide that you don’t want to know them, stop reading here.

The 5-year survival rate refers to the percentage of patients who live at least 5 years after their cancer is diagnosed. Of course, many people live much longer than 5 years (and many are cured). Also, although some people die of their cancer, others die from something else. These are observed survival rates, and include deaths from all causes, not just from cancer.

In order to get 5-year survival rates, doctors have to look at people who were treated at least 5 years ago. Improvements in treatment since then may result in a more favorable outlook for people now being diagnosed with endometrial cancer.

The survival rates below are based on the stage of the cancer at the time it was diagnosed. These rates do not apply to cancers that have come back after treatment or have spread after treatment starts.

Survival rates are based on previous outcomes of large numbers of people who had the disease, but they cannot predict what will happen in any particular person's case. Many other factors may affect a person's outlook, such as their general health and how well the cancer responds to treatment. Your doctor can tell you how the numbers below may apply to you, as he or she is familiar with the aspects of your particular situation.

The numbers below come from the National Cancer Data Base as published in the AJCC Staging Manual in 2010, and are based on people diagnosed between 2000 and 2002.

Endometrial adenocarcinoma


    5-year survival

    Stage 0


    Stage IA


    Stage IB


    Stage II


    Stage IIIA


    Stage IIIB


    Stage IIIC


    Stage IVA


    Stage IVB


The statistics for uterine carcinosarcoma are different from those given for endometrial adenocarcinoma in some important ways.

  • The numbers given are for 5-year relative survival. These rates assume that some people will die of other causes and compare the observed survival with that expected for people without the cancer. This can better show the impact of a particular type and stage of cancer on survival. Relative survival is generally higher than observed survival.
  • These numbers come from a different source -- the SEER program from the National Cancer Institute.
  • The stages listed are based on an older version of staging. In the most recent staging system, some of the cancers that were stage III might actually be considered stage I or II.

These differences in staging may make it more difficult to apply these numbers to your own situation.

Uterine carcinosarcoma


    5-year relative survival

    Stage I


    Stage II


    Stage III


    Stage IV


Last Medical Review: 01/12/2015
Last Revised: 03/17/2015